585 related articles for article (PubMed ID: 35198136)
1. Neurological manifestations of long-COVID syndrome: a narrative review.
Stefanou MI; Palaiodimou L; Bakola E; Smyrnis N; Papadopoulou M; Paraskevas GP; Rizos E; Boutati E; Grigoriadis N; Krogias C; Giannopoulos S; Tsiodras S; Gaga M; Tsivgoulis G
Ther Adv Chronic Dis; 2022; 13():20406223221076890. PubMed ID: 35198136
[TBL] [Abstract][Full Text] [Related]
2. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
[TBL] [Abstract][Full Text] [Related]
3. Post-COVID-19 neuropsychiatric manifestations: a suggested therapeutic approach to 'long COVID' with azithromycin.
Schwartz RA; Suskind RM
Epidemiol Infect; 2023 Dec; 152():e34. PubMed ID: 38097277
[TBL] [Abstract][Full Text] [Related]
4. Long COVID and neuropsychiatric manifestations (Review).
Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Smyrnis N; Rizos E
Exp Ther Med; 2022 May; 23(5):363. PubMed ID: 35493431
[TBL] [Abstract][Full Text] [Related]
5. New‑onset neuropsychiatric sequelae and 'long‑COVID' syndrome (Review).
Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Katsantoni E; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Ferentinos P; Smyrnis N; Rizos E
Exp Ther Med; 2022 Nov; 24(5):705. PubMed ID: 36324612
[TBL] [Abstract][Full Text] [Related]
6. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, pathogenesis and spectrum of neurological symptoms in COVID-19 and post-COVID-19 syndrome: a narrative review.
Wesselingh R
Med J Aust; 2023 Sep; 219(5):230-236. PubMed ID: 37660309
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics.
Leng A; Shah M; Ahmad SA; Premraj L; Wildi K; Li Bassi G; Pardo CA; Choi A; Cho SM
Cells; 2023 Mar; 12(5):. PubMed ID: 36899952
[TBL] [Abstract][Full Text] [Related]
9. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival.
Stefano GB; Ptacek R; Ptackova H; Martin A; Kream RM
Med Sci Monit; 2021 Jan; 27():e930886. PubMed ID: 33487628
[TBL] [Abstract][Full Text] [Related]
10. Pathological sequelae of long-haul COVID.
Mehandru S; Merad M
Nat Immunol; 2022 Feb; 23(2):194-202. PubMed ID: 35105985
[TBL] [Abstract][Full Text] [Related]
11. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
Patel UK; Mehta N; Patel A; Patel N; Ortiz JF; Khurana M; Urhoghide E; Parulekar A; Bhriguvanshi A; Patel N; Mistry AM; Patel R; Arumaithurai K; Shah S
Cureus; 2022 Sep; 14(9):e29694. PubMed ID: 36321004
[TBL] [Abstract][Full Text] [Related]
13. 'Long COVID' syndrome.
Taribagil P; Creer D; Tahir H
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33875508
[TBL] [Abstract][Full Text] [Related]
14. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies.
Dani M; Dirksen A; Taraborrelli P; Torocastro M; Panagopoulos D; Sutton R; Lim PB
Clin Med (Lond); 2021 Jan; 21(1):e63-e67. PubMed ID: 33243837
[TBL] [Abstract][Full Text] [Related]
15. What is really 'Long COVID'?
Szabo S; Zayachkivska O; Hussain A; Muller V
Inflammopharmacology; 2023 Apr; 31(2):551-557. PubMed ID: 36964860
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 atypical Parsonage-Turner syndrome: a case report.
Zazzara MB; Modoni A; Bizzarro A; Lauria A; Ciciarello F; Pais C; Galluzzo V; Landi F; Tostato M;
BMC Neurol; 2022 Mar; 22(1):96. PubMed ID: 35296278
[TBL] [Abstract][Full Text] [Related]
17. Post-COVID syndrome and suicide risk.
Sher L
QJM; 2021 Apr; 114(2):95-98. PubMed ID: 33486531
[TBL] [Abstract][Full Text] [Related]
18. An Overview of Neurological and Psychiatric Complications During Post-COVID Period: A Narrative Review.
Li D; Wang Q; Jia C; Lv Z; Yang J
J Inflamm Res; 2022; 15():4199-4215. PubMed ID: 35923904
[TBL] [Abstract][Full Text] [Related]
19. Neurological manifestations in coronavirus disease 2019.
Corona T; Rodríguez-Violante M; Delgado-García G
Gac Med Mex; 2020; 156(4):317-320. PubMed ID: 32831319
[TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary Management Strategies for Long COVID: A Narrative Review.
Prusinski C; Yan D; Klasova J; McVeigh KH; Shah SZ; Fermo OP; Kubrova E; Farr EM; Williams LC; Gerardo-Manrique G; Bergquist TF; Pham SM; Engelberg-Cook E; Hare JM; March KL; Caplan AI; Qu W
Cureus; 2024 May; 16(5):e59478. PubMed ID: 38826995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
